Trial · NCT02152761
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Epoch: Treatment Epoch | STARTED | Bimagrumab 700 mg | 75 | |
| Epoch: Treatment Epoch | STARTED | Bimagrumab 210 mg | 70 | |
| Epoch: Treatment Epoch | STARTED | Bimagrumab 70 mg | 34 | |
| Epoch: Treatment Epoch | STARTED | Placebo | 72 | |
| Epoch: Treatment Epoch | COMPLETED | Bimagrumab 700 mg | 64 | |
| Epoch: Treatment Epoch | COMPLETED | Bimagrumab 210 mg | 50 | |
| Epoch: Treatment Epoch | COMPLETED | Bimagrumab 70 mg | 29 | |
| Epoch: Treatment Epoch | COMPLETED | Placebo | 64 | |
| Epoch: Treatment Epoch | NOT COMPLETED | Bimagrumab 700 mg | 11 | |
| Epoch: Treatment Epoch | NOT COMPLETED | Bimagrumab 210 mg | 20 | |
| Epoch: Treatment Epoch | NOT COMPLETED | Bimagrumab 70 mg | 5 | |
| Epoch: Treatment Epoch | NOT COMPLETED | Placebo | 8 | |
| Epoch: Post-treatment Follow-up Epoch | STARTED | Bimagrumab 700 mg | 67 | |
| Epoch: Post-treatment Follow-up Epoch | STARTED | Bimagrumab 210 mg | 54 | |
| Epoch: Post-treatment Follow-up Epoch | STARTED | Bimagrumab 70 mg | 30 | |
| Epoch: Post-treatment Follow-up Epoch | STARTED | Placebo | 68 | |
| Epoch: Post-treatment Follow-up Epoch | COMPLETED | Bimagrumab 700 mg | 63 | |
| Epoch: Post-treatment Follow-up Epoch | COMPLETED | Bimagrumab 210 mg | 47 | |
| Epoch: Post-treatment Follow-up Epoch | COMPLETED | Bimagrumab 70 mg | 30 | |
| Epoch: Post-treatment Follow-up Epoch | COMPLETED | Placebo | 66 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02152761/flow